Neuroendocrine Tumors: Treatment and Management

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Aug 26

PMID 36011040

Authors

Alessio Imperiale

Affiliations

Soon will be listed here.

Abstract

This Topical Collection consists of a series of articles presented by a panel of internationally recognized experts and compiles several clinical accomplishments in the field of neuroendocrine tumors (NETs) [...].

References

Shah S, Gosain R, Groman A, Gosain R, Dasari A, Halfdanarson T . Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States. Cancers (Basel). 2021; 13(8). PMC: 8067543. DOI: 10.3390/cancers13081753. View

Cazzato R, Hubele F, De Marini P, Ouvrard E, Salvadori J, Addeo P . Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers (Basel). 2021; 13(24). PMC: 8699378. DOI: 10.3390/cancers13246368. View

de Ponthaud C, Menegaux F, Gaujoux S . Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know. Cancers (Basel). 2021; 13(23). PMC: 8656761. DOI: 10.3390/cancers13235969. View

Pellat A, Cottereau A, Palmieri L, Soyer P, Marchese U, Brezault C . Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions. Cancers (Basel). 2021; 13(10). PMC: 8158108. DOI: 10.3390/cancers13102448. View

Treglia G, Sadeghi R, Giovinazzo F, Galiandro F, Annunziata S, Muoio B . PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses. Cancers (Basel). 2021; 13(20). PMC: 8533943. DOI: 10.3390/cancers13205172. View

Ruhwedel T, Rogasch J, Huang K, Jann H, Schatka I, Furth C . The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis. Cancers (Basel). 2021; 13(4). PMC: 7915791. DOI: 10.3390/cancers13040635. View

Pellat A, Cottereau A, Terris B, Coriat R . Neuroendocrine Carcinomas of the Digestive Tract: What Is New?. Cancers (Basel). 2021; 13(15). PMC: 8345167. DOI: 10.3390/cancers13153766. View

Theiler D, Cattaneo M, Dierickx L, Igaz P, Grozinsky-Glasberg S, Bournaud C . Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers (Basel). 2021; 13(24). PMC: 8699207. DOI: 10.3390/cancers13246290. View

Alevroudis E, Spei M, Chatziioannou S, Tsoli M, Wallin G, Kaltsas G . Clinical Utility of F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis. Cancers (Basel). 2021; 13(8). PMC: 8069875. DOI: 10.3390/cancers13081813. View

10.

Bilski M, Mertowska P, Mertowski S, Sawicki M, Hymos A, Niedzwiedzka-Rystwej P . The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung. Cancers (Basel). 2022; 14(1). PMC: 8750397. DOI: 10.3390/cancers14010177. View

11.

Pasquer A, Walter T, Milot L, Hervieu V, Poncet G . Principles of Surgical Management of Small Intestinal NET. Cancers (Basel). 2021; 13(21). PMC: 8582489. DOI: 10.3390/cancers13215473. View

12.

Frey S, Mirallie E, Le Bras M, Regenet N . What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel). 2021; 13(23). PMC: 8656750. DOI: 10.3390/cancers13235954. View

13.

Takayanagi D, Cho H, Machida E, Kawamura A, Takashima A, Wada S . Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers (Basel). 2022; 14(5). PMC: 8909424. DOI: 10.3390/cancers14051119. View

14.

Addeo P, Cusumano C, Goichot B, Guerra M, Faitot F, Imperiale A . Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy. Cancers (Basel). 2022; 14(3). PMC: 8833522. DOI: 10.3390/cancers14030727. View

15.

Ahmadi Bidakhvidi N, Goffin K, Dekervel J, Baete K, Nackaerts K, Clement P . Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies. Cancers (Basel). 2022; 14(1). PMC: 8749814. DOI: 10.3390/cancers14010129. View